MARKET WIRE NEWS

Ariel Appreciation Fund Q1 2025 Commentary

Source: SeekingAlpha

2025-04-24 10:35:00 ET

Summary

  • Given the significant downturn since the quarter ended, we are closely monitoring the turn of events and assessing the situation daily.
  • Ariel Appreciation Fund decreased -6.94% in the quarter, underperforming both the Russell Midcap Value and Russell Midcap indices, which returned -2.11% and -3.40%, respectively.
  • Concerns for slower growth, higher inflation and mounting tail risks amidst tariffs fears and policy uncertainty continue to stoke recessionary fears.

Performance data quoted represents past performance. Past performance does not guarantee future results. All performance assumes the reinvestment of dividends and capital gains, and represents returns of the Investor Class shares. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. Performance data current to the most recent month-end for Ariel Appreciation Fund may be obtained by visiting our website, arielinvestments.com. For the period ended March 31, 2025, the average annual returns of Ariel Appreciation Fund (Investor Class) for the 1-, 5-, and 10-year periods were -4.94%, +13.56%, and +4.93%, respectively.

Read the full article on Seeking Alpha

For further details see:

Ariel Appreciation Fund Q1 2025 Commentary
Bio-Rad Laboratories Inc. Class A

NASDAQ: BIO

BIO Trading

11.5% G/L:

$277.42 Last:

471,754 Volume:

$274.72 Open:

mwn-ir Ad 300

BIO Latest News

BIO Stock Data

$8,088,674,023
21,121,296
0.01%
179
N/A
Biotechnology & Life Sciences
Healthcare
US
Hercules

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App